NASDAQ · KMTS
Healthcare · Medical - Instruments & Supplies
$25.18
Up+$1.12 (+4.66%)
Updated Sep 16, 2026, 10:55 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
KMTS closed at $25.18 after 20 trading sessions, down 9.85% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $21.90 | $25.4383 | $21.56 | $25.18 | 888.41K |
| Sep 14, 2026 | $22.87 | $24.43 | $22.795 | $24.06 | 747.23K |
| Sep 11, 2026 | $23.91 | $24.38 | $22.435 | $22.85 | 241.99K |
| Sep 10, 2026 | $23.45 | $24.425 | $23.25 | $23.57 | 310.5K |
| Sep 9, 2026 | $25.32 | $25.57 | $24.03 | $24.07 | 303.11K |
| Sep 8, 2026 | $25.45 | $25.83 | $24.87 | $25.635 | 349.57K |
| Sep 4, 2026 | $25.01 | $25.67 | $24.76 | $25.54 | 181.78K |
| Sep 3, 2026 | $26.14 | $26.14 | $24.82 | $25.14 | 200.38K |
| Sep 2, 2026 | $25.46 | $26.4997 | $25.095 | $25.73 | 245.54K |
| Sep 1, 2026 | $25.54 | $26.185 | $25.05 | $25.12 | 319.33K |
| Aug 31, 2026 | $25.38 | $25.90 | $25.06 | $25.75 | 351.3K |
| Aug 28, 2026 | $25.60 | $26.28 | $25.485 | $25.64 | 151.43K |
| Aug 27, 2026 | $26.56 | $27.244 | $25.78 | $25.81 | 198.31K |
| Aug 26, 2026 | $26.64 | $26.99 | $26.07 | $26.57 | 210.77K |
| Aug 25, 2026 | $27.24 | $27.5012 | $26.49 | $26.92 | 159.56K |
| Aug 24, 2026 | $26.98 | $27.53 | $26.24 | $26.91 | 171.36K |
| Aug 21, 2026 | $27.41 | $27.455 | $26.31 | $26.99 | 510.81K |
| Aug 20, 2026 | $27.49 | $28.11 | $27.00 | $27.26 | 246.91K |
| Aug 19, 2026 | $28.31 | $28.89 | $27.66 | $27.91 | 237.66K |
| Aug 18, 2026 | $27.55 | $28.33 | $26.69 | $27.93 | 249.3K |
The latest Smart Investors Daily articles mentioning KMTS.
KMTS research
Company profile and research snapshot.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 2, 2026 | BTIG | Buy | — |
| Aug 10, 2026 | JP Morgan | Overweight | — |
| Jul 21, 2026 | Oppenheimer | Perform | — |
| Jul 15, 2026 | BTIG | Buy | — |
| Apr 9, 2026 | Goldman Sachs | Neutral | — |
No generated briefing is available yet.
Benzinga · Sep 15, 2026
Kestra Medical fell 8.6% after missing earnings estimates despite beating sales forecasts; several other stocks also declined premarket.
Yahoo · Sep 15, 2026
Kestra Medical Technologies Ltd (KMTS) posted 60% revenue growth, a record 11th straight quarter of gross margin expansion, and raised its FY27 outlook on surging in-network mix and faster rep ramps.
Benzinga · Sep 15, 2026
BTIG analyst Marie Thibault reiterates Kestra Medical Techs (NASDAQ:KMTS) with a Buy and maintains $32 price target.
Benzinga · Sep 15, 2026
Veea shares surged 58% premarket on a NovaGen merger plan and $10M GeoNova investment, while other stocks posted notable gains and losses.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning KMTS.
